Sweat-powered sticker turns your drinking cup into a health sensor
Peer-Reviewed Publication
Updates every hour. Last Updated: 20-Dec-2025 15:11 ET (20-Dec-2025 20:11 GMT/UTC)
People with anxiety disorders have lower levels of choline in their brains, according to research from UC Davis Health. The study, published in the Nature journal Molecular Psychiatry, analyzed data from 25 studies. The researchers compared the levels of neurometabolites — chemicals produced during brain metabolism — in 370 people with anxiety disorders to 342 people without anxiety. They found the level of choline — an essential nutrient — was about 8% lower in those with anxiety disorders.
A physiology researcher believes a better understanding of the gut-brain connection can help explain dietary choices and lead to strategies for altering food preferences.
Obesity and cancer are two major health challenges of our time, yet the link between them remains only partially understood. New research now highlights a molecular chain of events in estrogen receptor-positive breast cancer, revealing how leptin, a hormone produced by fat cells, signals cancer cells to grow. This leads to increased activity of the enzyme stearoyl-CoA desaturase (SCD), which fuels the growth and motility of cancer cells. The findings from a study in The American Journal of Pathology, published by Elsevier, provides insights into the obesity–breast cancer link and identifies potential new therapeutic targets to counter obesity-driven breast cancer progression.
In a real-world clinical trial, published in JAMA Network Open, researchers demonstrate that a fully digital AI zero-cost method for detecting dementia can be scaled across primary care clinics. This breakthrough represents a major step forward in translating AI and patient-reported outcomes into everyday clinical care. By integrating scalable digital tools that operate seamlessly within existing health systems, the research team demonstrated how technology can strengthen early detection and improve outcomes for older adults as well as reduce burdens on primary care teams. The AI tool, which has been in development for more than 10 years at Regenstrief Institute, is a machine learning algorithm that uses natural language processing to analyze data from electronic health records. It identifies information such as memory issues, vascular concerns and other factors linked to dementia.